Showing results (41-50 of 85) with videos related to
Sort By:
Pageof 9
Journal of the National Comprehensive Cancer Network : JNCCN|November 13, 2024
Statin Use During Concurrent Chemoradiotherapy for Advanced Nasopharyngeal CancerJung-Min Yu, Chia-Lun Chang, Kuan-Chou Lin, et al.Soft Matter|November 11, 2020
Dendrimer-mediated columnar mesophase of surfactantsChih-Mei Young, Chia Lun Chang, Yu-Hsiang Chen, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 27, 2017
Treatment of advanced nasopharyngeal cancer using low- or high-dose concurrent chemoradiotherapy with intensity-modulated radiotherapy: A propensity score-matched, nationwide, population-based cohort studyTsung-Ming Chen, Kuan-Chou Lin, Kevin Sheng-Po Yuan, et al.Journal of Personalized Medicine|February 25, 2022
Adjuvant Radiotherapy Is Associated with an Increase in the Survival of Old (Aged over 80 Years) and Very Old (Aged over 90 Years) Women with Breast Cancer Receiving Breast-Conserving SurgeryChung-Chien Huang, Chia-Lun Chang, Mingyang Sun, et al.Computers, Informatics, Nursing : CIN|January 24, 2025
Acceptance of Virtual Reality Training for Chemotherapy Administration Among Nursing StudentsChia-Lun Chang, Shu-Chun Tsai, Chi-Yu Lu, et al.Cancers|October 30, 2019
Three-Dimensional Conformal Radiotherapy-Based or Intensity-Modulated Radiotherapy-Based Concurrent Chemoradiotherapy in Patients with Thoracic Esophageal Squamous Cell CarcinomaWei-Cheng Lin, Chia-Lun Chang, Han-Lin Hsu, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 24, 2023
Statin use reduces radiation-induced stroke risk in advanced nasopharyngeal carcinoma patientsChuan-Yi Lin, Chia-Lun Chang, Kuan-Chou Lin, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 4, 2023
Childhood body mass index trajectories and asthma and allergies: A systematic reviewChia-Lun Chang, Gulshan Bano Ali, Jonathan Pham, et al.Journal of Cancer|May 6, 2020
Outcomes of Adjuvant Oral versus Intravenous Fluoropyrimidines for High-Risk Stage II or Stage III Colon Adenocarcinoma: A Propensity Score-Matched, Nationwide, Population-Based Cohort StudyJiaqiang Zhang, Yu-Chun Yen, Lei Qin, et al.Plos One|May 30, 2023
Understanding the medication experience of patients with advanced non-small cell lung cancer taking epidermal growth factor receptor-tyrosine kinase inhibitors: A phenomenological studyMeng-Jung Wen, Han-Lin Hsu, Chia-Lun Chang, et al.Pageof 9